The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human dose escalation and food effect study of oral ONC206 in adults with recurrent primary CNS neoplasms.
 
Brett James Theeler
No Relationships to Disclose
 
Jinkyu Jung
No Relationships to Disclose
 
Eric Burton
No Relationships to Disclose
 
Heather Leeper
No Relationships to Disclose
 
Jing Wu
No Relationships to Disclose
 
Kareem Zaghloul
No Relationships to Disclose
 
Abhik Ray-Chaudhury
No Relationships to Disclose
 
Martha Quezado
No Relationships to Disclose
 
Mark Raffeld
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene/Juno; MicuRx Pharmaceuticals; SERVIER; Starpax Medical; Vertex
 
Kenneth D. Aldape
No Relationships to Disclose
 
Marta Penas-Prado
No Relationships to Disclose
 
Varun Vijay Prabhu
Employment - Chimerix; Oncoceutics
Leadership - Chimerix; Oncoceutics
Stock and Other Ownership Interests - Chimerix; Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
Travel, Accommodations, Expenses - Oncoceutics
 
Martin Stogniew
Employment - Oncoceutics
Leadership - Chimerix; Oncoceutics
Stock and Other Ownership Interests - Chimerix; Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
Travel, Accommodations, Expenses - Oncoceutics
 
Joshua E. Allen
Employment - Chimerix; Oncoceutics
Leadership - Chimerix; Oncoceutics
Stock and Other Ownership Interests - Chimerix; Chimerix; Oncoceutics; Oncoceutics
Patents, Royalties, Other Intellectual Property - ONC201-related patents; ONC201-related patents
Travel, Accommodations, Expenses - Oncoceutics; Oncoceutics; Oncoceutics; Oncoceutics; Oncoceutics
 
Terri S. Armstrong
No Relationships to Disclose
 
Mark R. Gilbert
No Relationships to Disclose